151 related articles for article (PubMed ID: 16972687)
1. [Paget's disease of bone].
Takata S
Nihon Rinsho; 2006 Sep; 64(9):1724-30. PubMed ID: 16972687
[TBL] [Abstract][Full Text] [Related]
2. [Paget's disease of bone].
Saura R
Clin Calcium; 2007 Nov; 17(11):1769-72. PubMed ID: 17982199
[TBL] [Abstract][Full Text] [Related]
3. [Therapeutic effects of risedronate on Paget's disease of bone].
Takata S
Clin Calcium; 2006 Sep; 16(9):1508-12. PubMed ID: 16951476
[TBL] [Abstract][Full Text] [Related]
4. Management of Paget's disease of bone.
Langston AL; Ralston SH
Rheumatology (Oxford); 2004 Aug; 43(8):955-9. PubMed ID: 15187244
[TBL] [Abstract][Full Text] [Related]
5. Guidelines for diagnosis and management of Paget's disease of bone in Japan.
Takata S; Hashimoto J; Nakatsuka K; Yoshimura N; Yoh K; Ohno I; Yabe H; Abe S; Fukunaga M; Terada M; Zamma M; Ralston SH; Morii H; Yoshikawa H
J Bone Miner Metab; 2006; 24(5):359-67. PubMed ID: 16937267
[TBL] [Abstract][Full Text] [Related]
6. A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg.
Abelson A
Curr Med Res Opin; 2008 Mar; 24(3):695-705. PubMed ID: 18226324
[TBL] [Abstract][Full Text] [Related]
7. Paget's disease of bone.
Siris ES
J Bone Miner Res; 1998 Jul; 13(7):1061-5. PubMed ID: 9661069
[TBL] [Abstract][Full Text] [Related]
8. Paget's disease of bone and calcium homeostasis: focus on bisphosphonate treatment.
Polyzos SA; Anastasilakis AD; Makras P; Terpos E
Exp Clin Endocrinol Diabetes; 2011 Oct; 119(9):519-24. PubMed ID: 21811962
[TBL] [Abstract][Full Text] [Related]
9. Medical management of Paget's disease of bone: indications for treatment and review of current therapies.
Siris ES; Lyles KW; Singer FR; Meunier PJ
J Bone Miner Res; 2006 Dec; 21 Suppl 2():P94-8. PubMed ID: 17229018
[TBL] [Abstract][Full Text] [Related]
10. Paget's disease.
Bender IB
J Endod; 2003 Nov; 29(11):720-3. PubMed ID: 14651277
[TBL] [Abstract][Full Text] [Related]
11. Serum OPG and RANKL levels before and after intravenous bisphosphonate treatment in Paget's disease of bone.
Martini G; Gennari L; Merlotti D; Salvadori S; Franci MB; Campagna S; Avanzati A; De Paola V; Valleggi F; Nuti R
Bone; 2007 Feb; 40(2):457-63. PubMed ID: 16979395
[TBL] [Abstract][Full Text] [Related]
12. Current treatment approaches for Paget's Disease of Bone.
Brandi ML
Discov Med; 2010 Sep; 10(52):209-12. PubMed ID: 20875342
[TBL] [Abstract][Full Text] [Related]
13. Midterm outcome of risedronate therapy for patients with Paget's disease of bone in the central part of Japan.
Nishida Y; Yamada Y; Tsukushi S; Sugiura H; Urakawa H; Ishiguro N
Clin Rheumatol; 2013 Feb; 32(2):241-5. PubMed ID: 23138882
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility to Paget's disease of bone is influenced by a common polymorphic variant of osteoprotegerin.
Daroszewska A; Hocking LJ; McGuigan FE; Langdahl B; Stone MD; Cundy T; Nicholson GC; Fraser WD; Ralston SH
J Bone Miner Res; 2004 Sep; 19(9):1506-11. PubMed ID: 15312251
[TBL] [Abstract][Full Text] [Related]
15. [Paget's disease of bone and basilar impression associated with an Arnold-Chiari type-1 malformation].
Iglesias-Osma C; Gómez Sánchez JC; Suquia Múgica B; Querol Prieto R; de Portugal Alvarez J
An Med Interna; 1997 Oct; 14(10):519-22. PubMed ID: 9424143
[TBL] [Abstract][Full Text] [Related]
16. Risedronate and pamidronate treatment in the clinical management of patients with severe Paget's disease of bone and acquired resistance to bisphosphonates.
Rendina D; Mossetti G; Viceconti R; Sorrentino M; Nunziata V
Calcif Tissue Int; 2004 Sep; 75(3):189-96. PubMed ID: 15148558
[TBL] [Abstract][Full Text] [Related]
17. Dickkopf-1 as a potential therapeutic target in Paget's disease of bone.
McCarthy HS; Marshall MJ
Expert Opin Ther Targets; 2010 Feb; 14(2):221-30. PubMed ID: 20055719
[TBL] [Abstract][Full Text] [Related]
18. [Action of calcitonin on osteoclasts in Paget's bone disease during long term treatment (author's transl)].
Rebel A; Basle M; Minard MF; Malkani K
Pathol Biol (Paris); 1977 Nov; 25(9):611-6. PubMed ID: 202910
[TBL] [Abstract][Full Text] [Related]
19. Contribution of genetic factors to the pathogenesis of Paget's disease of bone and related disorders.
Lucas GJ; Daroszewska A; Ralston SH
J Bone Miner Res; 2006 Dec; 21 Suppl 2():P31-7. PubMed ID: 17229006
[TBL] [Abstract][Full Text] [Related]
20. Paget's disease of bone: diagnosis and treatment update.
Noor M; Shoback D
Curr Rheumatol Rep; 2000 Feb; 2(1):67-73. PubMed ID: 11123042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
